WALKING DISABILITY side effect
What is WALKING DISABILITY ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
WALKING DISABILITY and Recently Reported Side Effects
WALKING DISABILITY and 15 most Active Side Effect polls
WALKING DISABILITY and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with WALKING DISABILITY
ARIXTRA CARDENSIEL DOBUPAL FLUVASTATIN LOTENSIN NUTROPIN REMICADELotensin Side Effects Report #5486280-2
Consumer or non-health professional from CHINA reported LOTENSIN problem on Oct 08, 2007. Female patient was treated with LOTENSIN. After drug was administered, patient experienced the following problems/side effects: walking disability, . LOTENSIN dosage: 5 MG, QD. During the same period patient was treated with ISOSORBIDE DINITRATE. Patient recovered.
Nutropin Side Effects Report #5485568-9
NUTROPIN AQ problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2007. Male patient, weighting 29.99 lb, was diagnosed with growth hormone deficiency, body height below normal and was treated with NUTROPIN AQ. After drug was administered, patient experienced the following problems/side effects: speech disorder, walking disability, . NUTROPIN AQ dosage: 0.6 ML, QD. During the same period patient was treated with NUTROPIN AQ, VITAMIN B, VITAMINS NOS. Patient recovered.
Nutropin Side Effects Report #5468201-1
Consumer or non-health professional from UNITED STATES reported NUTROPIN AQ problem on Sept 20, 2007. Male patient, weighting 29.99 lb, was diagnosed with growth hormone deficiency, body height below normal and was treated with NUTROPIN AQ. After drug was administered, patient experienced the following problems/side effects: speech disorder, walking disability, . NUTROPIN AQ dosage: 0.6 ML, QD. During the same period patient was treated with NUTROPIN AQ, VITAMIN B, VITAMINS NOS. Patient recovered.
Nutropin Side Effects Report #5368066-2
NUTROPIN AQ problem was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2007. Male patient, weighting 29.99 lb, was diagnosed with growth hormone deficiency and was treated with NUTROPIN AQ. After drug was administered, patient experienced the following problems/side effects: speech disorder, walking disability, . NUTROPIN AQ dosage: 0.6 ML, QD. During the same period patient was treated with VITAMIN B, VITAMINS NOS. Patient recovered.
Nutropin Side Effects Report #5375403-1
Consumer or non-health professional from UNITED STATES reported NUTROPIN AQ problem on June 22, 2007. Male patient, weighting 29.99 lb, was diagnosed with growth hormone deficiency, body height below normal and was treated with NUTROPIN AQ. After drug was administered, patient experienced the following problems/side effects: speech disorder, walking disability, . NUTROPIN AQ dosage: 0.6 ML, QD. During the same period patient was treated with NUTROPIN AQ, VITAMIN B, VITAMINS NOS. Patient recovered.
Cardensiel Side Effects Report #5284320-7
CARDENSIEL problem was reported by a Consumer or non-health professional from FRANCE on Mar 16, 2007. Male patient, 55 years of age, was diagnosed with ischaemic cardiomyopathy and was treated with CARDENSIEL. After drug was administered, patient experienced the following problems/side effects: pain in extremity, walking disability, . CARDENSIEL dosage: 1,25 MG (1,25 MG, 1 D), ORAL. During the same period patient was treated with IKOREL, COVERSYL, ASPEGIC, ELISOR, OGAST. Patient recovered.
Dobupal Side Effects Report #5520557-7
Health Professional from SPAIN reported DOBUPAL problem on Nov 13, 2007. Male patient, 45 years of age, was diagnosed with depression and was treated with DOBUPAL. After drug was administered, patient experienced the following problems/side effects: muscle contractions involuntary, muscle spasms, walking disability, . DOBUPAL dosage: 150 MG PER DAY. Patient recovered.
Fluvastatin Side Effects Report #5777342-0
FLUVASTATIN problem was reported by a Consumer or non-health professional from GERMANY on June 11, 2008. Male patient, weighting 149.9 lb, was diagnosed with hypercholesterolaemia and was treated with FLUVASTATIN. After drug was administered, patient experienced the following problems/side effects: myopathy, myositis, walking disability, . FLUVASTATIN dosage: 80 MG, QD. Patient recovered.
Arixtra Side Effects Report #5781929-9
Consumer or non-health professional from FRANCE reported ARIXTRA problem on June 11, 2008. Female patient, 59 years of age, was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: haematoma, pain in extremity, walking disability, . ARIXTRA dosage: 2.5MG PER DAY. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5695548-6
REMICADE problem was reported by a Physician from GREECE on Mar 26, 2008. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: paresis, polyneuropathy, walking disability, . REMICADE dosage: unknown. During the same period patient was treated with ENDOXAN. Patient was hospitalized and became disabled. Patient recovered.
Remicade Side Effects Report #5707828-6
Physician from GREECE reported REMICADE problem on Apr 08, 2008. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: paresis, polyneuropathy, walking disability, . REMICADE dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.